Hemorrhoid Treatment Devices Market Industry Report, Size, Share, and Analysis, 2018-2026


Posted July 8, 2019 by VedantR

Treatment for hemorrhoid disease includes non-surgical treatment and surgical treatment. Non-surgical treatment includes laxatives and corticosteroids.

 
Hemorrhoid is a common disease in a general population, which is also known as the piles, where the patient suffers from painless bleeding during bowel movement, itching and irritation in anal side, swelling of anal veins, pain and discomfort, and formation of lumps near to anus, which is sensitive and painful. Hemorrhoid is distinguished into two parts such as internal hemorrhoid and external hemorrhoid.

Treatment for hemorrhoid disease includes non-surgical treatment and surgical treatment. Non-surgical treatment includes laxatives and corticosteroids. Surgical treatment includes banding, sclerotherapy, infrared coagulation, hemorrhoidectomy, and hemorrhoid sampling. Various devices are used for the treatment of hemorrhoid such as endoscopic rubber band ligator, hemorrhoidal multi-band ligator, disposable hemorrhoid banding system, mcgivney hemorrhoidal ligator, endoscopic infrared coagulator, and lumatec infrared coagulator.

New product launches is expected to drive the global hemorrhoid treatment devices market size. For instance, in March 2019, De Scalene launched a new device called Cryocure, an affordable device to treat hemorrhoid without surgery. Cryocure helps to stop the bleeding from anal blood vessels and constriction of that anal blood vessels.

Free Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/2647

Furthermore, increasing incidence and prevalence of hemorrhoid disease in the U.S. is expected to drive the global hemorrhoid treatment devices market growth. For instance, in March 2016, according to the National Center for Biotechnology Information (NCBI), overall prevalence of hemorrhoid disease in the general population is around 4.4% and self-reported incidence of hemorrhoid disease is around 10 million persons, annually in the U.S.

For instance, in January 2018, PRIVI MEDICAL PTE. LTD., received U.S. FDA clearance for its new device (Instalief), which is used for the hemorrhoid treatment. Instalief is the drug-free device, which provides the instant cold relief without any side-effects.

Majority of market players in the global hemorrhoid treatment devices market such as Zhengzhou Safute Electronic Equipment Co., Ltd., and Wuxi Shenkang Medical Instrument Equipment Co. Ltd belong to China. These companies include various hemorrhoid treatment devices such as anorectal physical therapy device, SAFUTE hemorrhoid surgery device, and sigmoid colon and hemorrhoid disease treating device.

Key players operating in the global hemorrhoid treatment device market include Johnson & Johnson, PRIVI MEDICAL PTE. LTD., Cook Medical, Medtronic Plc, Integra LifeSciences Corporation, OBP Medical Corporation, Boston Scientific Corporation, Sklar Surgical Instruments, Surkon Medical Co., Ltd., and CONMED Corporation.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2647
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr.Shah
Phone 12067016702
Business Address 1001 4th Ave,
#3200
Country United States
Categories Advertising , Health , Industry
Tags hemorrhoid treatment devices market industry , hemorrhoid treatment devices market size , hemorrhoid treatment devices market
Last Updated July 8, 2019